Anti-SARS-CoV-2 Spike negative/non-reactive and positive/reactive controls are intended for use with in vitro assays for the determination of spike antibodies to SARS-CoV-2.
These controls are unassayed and are suitable for use on various analysers, therefore making them useful in determining the precision of testing systems and allows performance monitoring of multiple test systems.
Benefits
• Liquid ready-to-use
• 100% human plasma
• Reactive and non-reactive controls available
• Stable to expiry date at 2ºC to 8ºC
• Open vial stability of 30 days at 2ºC to 8ºC
Want to know more?
Contact us or visit our Acusera page to learn more.